Amydis Diagnostics
Phase 2Amydis is the leader in developing a new class of diagnostic compounds that enable digital detection and monitoring of human disease-related molecular biomarkers through standard ocular imaging cameras.
Founded
2018
Focus
Diagnostics
About
Amydis is the leader in developing a new class of diagnostic compounds that enable digital detection and monitoring of human disease-related molecular biomarkers through standard ocular imaging cameras.
Funding History
2Total raised: $3M
Grant$500KNational Institutes of Health (NIH)Mar 15, 2022
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile